Sanofi Aventis SA, the world's third largest Drugmaker, said Wednesday its second quarter net profit rose 91 percent in spite of the impact of generics and the increased launch costs of new drugs.
French Drugmaker Sanofi Aventis Q Net profit up 91 percent.